Published 2020-04-01
“…In the compound-target network of Niuxi in treating Wei syndrome of OA, the key compound node of Niuxi was baicalin, which belonged to flavonoids, and the key target node was MMP-1.Conclusion:Computer simulation intuitively showed the multi-target effects of Niuxi in simultaneously treating Wei syndrome and Bi syndrome of OA through the modes like
promiscuous drug and combination drug. This could provide a basis for Niuxi therapeutic for OA and new drug development from Niuxi.…”
Get full text
Article